Clinical Guides
Constipation in Adults
A source-grounded guide to recognising, evaluating and managing constipation in adults, including alarm features, secondary causes, pelvic-floor dysfunction, pregnancy, refractory disease and the limits of transferring international guidance into Indian practice.
MedNext Academy | 14 min read
Constipation in Adults
A source-grounded guide to recognising, evaluating and managing constipation in adults, including alarm features, secondary causes, pelvic-floor dysfunction, pregnancy, refractory disease and the limits of transferring international guidance into Indian practice.
Summary
Constipation is not defined by stool frequency alone. Adults may report hard or lumpy stool, straining, prolonged toileting, a sense of incomplete evacuation or blockage, manual manoeuvres, or fewer spontaneous bowel movements. Establish what has changed from the person's usual pattern, how long symptoms have lasted, and whether pain is the dominant symptom. Functional constipation, constipation-predominant irritable bowel syndrome, a defecatory disorder and slow-transit constipation overlap clinically but have different implications when first-line care fails.
Assessment starts by looking for an urgent organic cause, then medicines, metabolic or neurological contributors, and anorectal symptoms. Rectal bleeding, iron-deficiency anaemia, unexplained weight loss, a palpable mass, persistent vomiting, severe distension, fever, family history of colorectal cancer or a new sustained change in bowel habit require risk-based investigation rather than repeated laxatives. A careful digital rectal examination can identify impaction and suggest pelvic-floor incoordination, but a normal examination neither excludes cancer nor proves normal evacuation.
Most uncomplicated cases can begin with education, a realistic fibre and fluid plan, physical activity suited to the person, regular unhurried toileting and an osmotic or other evidence-supported laxative chosen for symptoms and comorbidity. Escalate treatment stepwise and review response, adherence and adverse effects. Refractory symptoms require diagnostic reconsideration, not endless dose escalation. Anorectal testing and pelvic-floor biofeedback are particularly important when evacuation is difficult. This reviewed educational guide is educational and has been approved by the MedNext Clinical Team.
How Common Is It?
Chronic constipation is common worldwide, but prevalence estimates vary substantially with the definition, age, sex, sampling method and whether people are asked about frequency or the broader experience of difficult evacuation. The 2020 Gastroenterology review cites a worldwide prevalence around 15%, while the Indian consensus concludes that constipation is common and probably under-reported in India. Neither figure should be converted into a precise prediction for an individual clinic or state. Community symptoms, self-perceived constipation and specialist diagnoses represent different populations.
Women, older adults, people with reduced mobility and those taking constipating medicines are often over-represented, but constipation is not a normal or harmless consequence of ageing. Indian dietary patterns are heterogeneous. A vegetarian diet does not guarantee adequate soluble fibre, and high cereal or insoluble-fibre intake can coexist with bloating, difficult evacuation or slow transit. Squatting versus seated toilet use, privacy, working hours, travel, water access and reluctance to discuss anorectal symptoms can affect presentation.
Burden is better measured through symptoms and function than a national percentage. Ask about painful passage, time spent toileting, digital assistance, faecal leakage around impaction, appetite, sleep, work, travel and quality of life. A stool diary and Bristol Stool Form Scale can establish a baseline. Under-reporting is especially likely in older adults, people dependent on carers and patients embarrassed by manual manoeuvres. Published prevalence does not justify screening every asymptomatic adult, but persistent or troublesome symptoms deserve structured assessment rather than reassurance based solely on having several bowel movements each week.
Risk Factors
Potential contributors fall into lifestyle, medicine, systemic, neurological, structural and pelvic-floor groups. Low intake of fibre or fluid may contribute in some people, as can immobility, disrupted routines and repeatedly suppressing the urge to defecate. More fibre is not universally better: a person already eating a high-fibre diet, experiencing marked bloating, or having faecal impaction or an evacuation disorder may feel worse with indiscriminate bran. Assess actual food, fluid, activity and toilet circumstances without attributing disease to motivation.
Common medicine contributors include opioids, anticholinergic drugs, tricyclic antidepressants, some antipsychotics, iron and calcium supplements, aluminium-containing antacids, calcium-channel blockers such as verapamil, diuretics through dehydration, and medicines used in Parkinson disease or epilepsy. The indication and risk of stopping each medicine must be reviewed; abrupt withdrawal can be dangerous. Opioid-induced constipation has a distinct mechanism and may require a targeted pathway.
Secondary medical causes include hypothyroidism, hypercalcaemia, hypokalaemia, diabetes with autonomic neuropathy, chronic kidney disease, dehydration, pregnancy, depression, eating disorders and connective-tissue disease. Neurological causes include Parkinson disease, multiple sclerosis, spinal cord or cauda equina disease, stroke and autonomic neuropathy. Colorectal cancer, strictures, rectocele, prolapse and painful anal disease are structural considerations. Prior pelvic surgery, childbirth injury and chronic straining can accompany defecatory disorders. Risk factors help focus evaluation but do not diagnose the mechanism. A new pattern with alarm features must not be dismissed because a constipating medicine or familiar lifestyle factor is also present.
Diagnosis
The diagnostic task is to characterise the symptom, exclude time-critical or structural disease, identify secondary causes and recognise difficult evacuation. Do not label chronic idiopathic constipation before reviewing the clinical context.
History
Ask onset, duration, stool frequency and form, straining, blockage, incomplete emptying, digital assistance, urgency, leakage, pain and bloating. Clarify whether abdominal pain relates to defecation, which may support IBS-C, and ask about bleeding, weight, appetite, fever, vomiting and family cancer history. Review diet, fluid, activity, toilet access, pregnancy possibility, operations, obstetric history, neurological symptoms, endocrine disease and every prescribed, non-prescribed and traditional remedy. Establish prior trials accurately rather than accepting the word refractory.
Examination
Assess hydration, nutrition and systemic illness; examine the abdomen for distension, tenderness, stool or a mass. Inspect the perineum when indicated. With consent, privacy and a chaperone, digital rectal examination can assess impaction, blood, mass, anal tone, squeeze and the pattern during simulated evacuation. Paradoxical contraction or failure of perineal descent may suggest dyssynergia, but bedside examination is operator-dependent. Perform focused neurological examination when symptoms suggest spinal or peripheral disease.
Investigations
Tests follow findings rather than a fixed panel. Full blood count, thyroid, calcium, glucose, electrolytes, renal function, coeliac testing or pregnancy testing may be appropriate when the history suggests them. Constipation alone does not mandate colonoscopy; investigate alarm features and colorectal-cancer screening eligibility through current local pathways. Persistent evacuation symptoms after adequate first-line therapy may require anorectal manometry plus balloon expulsion, with defecography selectively. Colonic transit testing is considered after a defecatory disorder is assessed or treated. No single test defines every mechanism.
Differential Diagnosis
Functional constipation describes persistent difficult, infrequent or incomplete defecation without an identified structural or biochemical cause. IBS-C requires recurrent abdominal pain linked to defecation or altered stool pattern; bloating alone is insufficient. A defecatory disorder causes impaired rectal evacuation, often signalled by prolonged straining, blockage, incomplete emptying, vaginal or perineal pressure, or digital manoeuvres. Slow-transit constipation more often involves infrequent urge and bowel movements, although symptoms cannot reliably distinguish mechanisms. These categories can coexist.
Faecal impaction may cause pain, urinary symptoms, confusion in a frail adult or overflow liquid stool mistaken for diarrhoea. Anal fissure and painful haemorrhoidal disease can cause voluntary withholding. Rectocele, intussusception, prolapse, stricture and postoperative anatomy can obstruct evacuation. Colorectal cancer must be considered with rectal bleeding, iron-deficiency anaemia, weight loss, a mass, relevant family history or a persistent new change in habit; the absence of constipation does not exclude it, and constipation alone is not proof of cancer.
Secondary causes include hypothyroidism, hypercalcaemia, electrolyte disturbance, diabetes, pregnancy, neurological disease and constipating medicines. Acute severe constipation with vomiting and distension raises mechanical obstruction, pseudo-obstruction or volvulus rather than uncomplicated functional disease. Opioid-induced constipation, neurogenic bowel and constipation in palliative care need tailored pathways.
Also distinguish a patient's expectation of daily stool from true troublesome dysfunction. Conversely, apparently normal frequency can conceal severe evacuation difficulty. Rumination about stool frequency, eating disorders and depression may modify symptoms, but psychological comorbidity must not be used to dismiss bleeding, objective weight loss, anaemia, impaction or abnormal examination.
Management
Agree a target such as comfortable soft formed stool without prolonged straining, not an arbitrary daily bowel movement. Explain the colon's normal variability and the cycle by which painful stool, withholding and harder stool reinforce one another. Review constipating medicines and treat a reversible systemic cause. Encourage regular meals, feasible movement and a consistent unhurried toilet opportunity, often after breakfast when the gastrocolic response is active. A foot support can improve posture on a seated toilet. Do not prescribe excessive water or fibre as universal cures; increase soluble fibre gradually only when appropriate and ensure adequate fluid with bulking agents.
Choose treatment by stool consistency, frequency, evacuation symptoms, comorbidity, cost and availability. Polyethylene glycol has strong guideline support for chronic idiopathic constipation. Other osmotic agents, soluble fibre and stimulant laxatives can be appropriate; stimulants are not automatically forbidden but need an indication, counselling and review. If one mechanism is inadequate, a rational combination may be better than repeatedly switching without measurement. Record a trial's dose, duration, adherence, stool response and adverse effects.
Persistent outlet symptoms should prompt anorectal evaluation. Instrument-guided pelvic-floor biofeedback is preferred for confirmed defecatory dysfunction and is not equivalent to generic advice to exercise the pelvic floor. Newer secretagogues or prokinetic agents may be considered after suitable over-the-counter therapy fails, subject to Indian licensing, affordability and contraindications.
For refractory disease, reassess diagnosis, adherence, secondary causes and pelvic-floor function before declaring treatment failure. Confirm slow transit and exclude evacuation disorder before contemplating surgery. Colectomy is reserved for exceptional, carefully selected patients after specialist physiological and multidisciplinary assessment; it is not a response to severe symptoms alone.
Prescribing Information
Fibre supplements may improve stool frequency, especially when baseline intake is low, but can increase bloating and require adequate fluid. Avoid unsupervised bulk-forming agents in suspected obstruction, severe impaction or swallowing difficulty. Polyethylene glycol draws water into stool and is evidence-supported; nausea, bloating and loose stool can occur. Lactulose may be useful when alternatives are unavailable or unsuitable but commonly causes gas. Magnesium-containing laxatives require caution or avoidance in renal impairment because magnesium can accumulate. Product composition and licensed directions differ, so use a current Indian formulary rather than copying a foreign dose table.
Bisacodyl, sodium picosulfate and senna stimulate bowel activity. They can be used as rescue or within a reviewed regimen; cramps and diarrhoea are common dose-limiting effects. Rectal suppositories or enemas may be appropriate for distal impaction or selected neurogenic-bowel plans, but repeated unsupervised phosphate enemas can cause serious electrolyte and renal harm. Docusate has limited evidence for chronic idiopathic constipation and should not displace effective therapy simply because it is called a stool softener.
Linaclotide, lubiprostone, plecanatide and prucalopride have evidence in selected adults who do not respond to over-the-counter options, but availability, price, licensing, pregnancy data, interactions and adverse-effect profiles vary. Opioid-induced constipation may warrant a peripherally acting mu-opioid receptor antagonist after obstruction is excluded and the opioid plan reviewed.
During pregnancy, begin with food, fluid, activity and toileting measures; bulk-forming agents and poorly absorbed osmotic laxatives are commonly considered, but formulation and individual obstetric risk require clinician review. Avoid assuming that newer agents, herbal mixtures or castor oil are safe. Every prescription needs a target, stop rule and follow-up date.
When to Refer
Arrange emergency assessment for suspected bowel obstruction or perforation: severe or escalating abdominal pain, persistent vomiting, marked distension, peritonism, systemic instability or inability to pass stool and flatus in the appropriate context. New constipation with acute urinary retention, saddle sensory change, progressive leg weakness or loss of anal tone requires an urgent spinal pathway. Significant gastrointestinal bleeding or severe symptomatic anaemia also needs prompt escalation.
Refer urgently through an appropriate gastrointestinal or colorectal pathway when alarm features suggest malignancy or other organic disease. These include a persistent unexplained change in bowel habit, visible bleeding, iron-deficiency anaemia, weight loss, a palpable abdominal or rectal mass, or important family history. Age modifies baseline risk but should be interpreted with current Indian cancer pathways rather than used as a lone fixed threshold.
Routine specialist referral is appropriate when symptoms remain troublesome after an adequate, documented first-line plan; impaction recurs; there is substantial manual assistance, prolapse or suspected rectocele; a neurological bowel disorder is present; or diagnosis is uncertain. Gastroenterology or a motility service can arrange anorectal manometry, balloon expulsion, defecography and transit studies in the right sequence. Pelvic-floor physiotherapy should offer instrumented biofeedback when dyssynergic defecation is confirmed.
Pregnant patients with severe, refractory symptoms, bleeding, vomiting or complex comorbidity need obstetric and relevant specialist input. Frail adults may benefit from geriatric, pharmacy, dietetic and continence review. Referral letters should state alarm review, examination including DRE if performed, medicine contributors, investigations and precisely what treatment was tried.
Red Flags
Rectal bleeding, melaena, iron-deficiency anaemia, unexplained weight loss, anorexia, fever, nocturnal progressive symptoms, a palpable abdominal or rectal mass and a sustained new change in bowel habit demand assessment for organic disease. Family history of colorectal cancer or a hereditary cancer syndrome lowers the threshold for investigation. Never explain away bleeding as haemorrhoids without considering the whole risk pattern. Constipation can accompany colorectal cancer but is neither a sensitive nor a specific cancer test.
Severe colicky or constant abdominal pain, repeated vomiting, marked distension, peritoneal signs, fever, tachycardia, hypotension or failure to pass flatus suggests obstruction, volvulus, pseudo-obstruction, ischaemia or perforation. Stop oral bulking strategies and arrange urgent care. In a frail or neurologically impaired adult, paradoxical diarrhoea, anorectal pain, urinary retention, delirium or reduced appetite may signal faecal impaction.
New constipation or incontinence with saddle anaesthesia, bilateral radicular pain, leg weakness, altered reflexes or bladder dysfunction raises cauda equina or spinal cord disease. Severe headache, bradycardia or autonomic symptoms during bowel care in a high spinal injury patient may indicate autonomic dysreflexia.
Medicine toxicity is another red-flag category: dehydration and renal injury after excessive purging, hypermagnesaemia in renal failure, electrolyte disturbance after phosphate enemas, or severe diarrhoea from stacked therapies. Pregnancy with pain, bleeding, vomiting or systemic illness should not be managed as routine constipation. Clinical deterioration, an abnormal examination or a failed reasonable treatment trial must trigger diagnostic reconsideration rather than escalating laxatives indefinitely.
Indian Clinical Context
The 2018 joint Indian consensus is the most directly relevant source used here. It recognises that chronic constipation is common in India, that Western assumptions about stool frequency and diet do not transfer neatly, and that faecal evacuation disorders and slow transit contribute in tertiary practice. Its age threshold for alarm-led invasive investigation reflects the evidence and practice context available at that time; clinicians should now combine symptom risk with current colorectal-cancer screening and referral policies rather than apply an old number mechanically.
Food patterns, toilet design and healthcare access vary widely across India. Ispaghula is affordable and familiar but is not suitable for every bloated or impacted patient. Polyethylene glycol availability and formulation, access to linaclotide or prucalopride, and out-of-pocket cost vary. Anorectal manometry, balloon expulsion testing and trained biofeedback may be concentrated in urban centres. Where testing is unavailable, early specialist discussion is safer than labelling a patient permanently refractory or proceeding to surgery without physiological confirmation.
Ask neutrally about ayurvedic, herbal and over-the-counter purgatives. Some products have uncertain composition, and concurrent remedies can explain diarrhoea, electrolyte disturbance or apparent treatment failure. Respect squatting or seated toilet preference and adapt posture advice to mobility, arthritis and household facilities. Privacy, gender concordance and a chaperone can determine whether a patient accepts DRE.
The AGA-ACG pharmacological guideline is a high-quality international source, not an Indian formulary. Regulatory approval, brands, contraindications and prices require local verification. This guide does not claim a national adult-constipation pathway beyond the cited Indian consensus, and it remains quarantined until organizational clinical review.
NMC Competency Mapping
Constipation integrates gastrointestinal history, abdominal and rectal examination, pharmacology, nutrition, endocrinology, neurology, obstetrics, geriatrics and cancer recognition. The NMC CBME Curriculum 2024 provides the educational framework, but this draft does not assert a single disease-specific constipation competency code without a verified curriculum mapping ledger. Learners should be able to describe bowel habit precisely, elicit alarm features, identify secondary causes and distinguish functional constipation, IBS-C, impaction and a likely defecatory disorder.
At a show-how level, a learner should take consent for abdominal and digital rectal examination, offer a chaperone, preserve dignity and describe what DRE can and cannot establish. Interpretation exercises can use a stool diary, Bristol Stool Form Scale, full blood count showing iron deficiency, a medicine list containing opioids or anticholinergics, and a balloon-expulsion or anorectal-manometry report. The safe answer often depends on sequencing rather than ordering every available test.
Prescribing competencies include matching soluble fibre, osmotic and stimulant laxatives to context; recognising renal cautions with magnesium, electrolyte risk with phosphate enemas, and medicine contributors; and documenting response and review. Communication stations can address pregnancy, caregiver-supported bowel care and fear of colorectal cancer without false reassurance.
Integration with surgery and oncology should reward recognition of obstruction, bleeding, anaemia, mass and persistent change in habit. Advanced learners should explain why pelvic-floor biofeedback treats dyssynergia and why colectomy requires confirmed slow transit and exclusion of evacuation disorder. Curriculum mapping supports learning; it does not constitute clinical approval of this draft.
Key Exam Pearls for NEET PG
Constipation includes hard stool, straining, incomplete evacuation, anorectal blockage, manual manoeuvres and reduced frequency. IBS-C requires recurrent abdominal pain as a defining feature; functional constipation does not. Defecatory disorders are suggested by excessive straining, blockage and digital assistance, while slow transit often produces infrequent urge. Symptoms overlap, so physiology testing becomes important after a proper first-line trial. Overflow liquid stool around impaction is not true recovery and can be mistaken for diarrhoea.
Always look for a secondary cause: opioids, anticholinergics, iron, calcium, verapamil, hypothyroidism, hypercalcaemia, hypokalaemia, diabetes, pregnancy and neurological disease are classic associations. Cancer warnings include bleeding, iron-deficiency anaemia, weight loss, mass, family history and a persistent new change in bowel habit. Constipation alone is not an indication for routine colonoscopy; alarm risk and screening status drive investigation.
DRE can detect impaction, rectal lesions and abnormal simulated evacuation, but it is operator-dependent. Failure of appropriate over-the-counter therapy with outlet symptoms should lead to anorectal manometry and balloon expulsion; defecography is selective. Treat confirmed dyssynergia with instrumented biofeedback. Assess or treat the outlet disorder before interpreting slow transit because retention can secondarily delay colonic transit.
Polyethylene glycol has strong evidence. Stimulants can be used rationally and are not universally prohibited. Magnesium requires renal caution; phosphate enemas can cause major electrolyte harm. Confirm slow transit, exclude pelvic-floor dysfunction and exhaust appropriate therapy before surgery. In pregnancy, choose conservative and poorly absorbed options with obstetric and formulary review rather than assuming every over-the-counter or herbal product is safe.
Frequently Asked Questions
Does a healthy adult need to open their bowels every day?
No. Normal frequency varies, and a daily motion is not required if stool passes comfortably without troublesome straining, hardness, blockage or incomplete emptying. Assessment should focus on a sustained change from the person's baseline, stool form, evacuation symptoms and effect on life. Bleeding, weight loss, anaemia, vomiting or marked distension needs medical assessment regardless of frequency.
When does constipation need investigation for colorectal cancer?
Constipation by itself is not a reliable cancer marker. Investigation becomes more important with a persistent new change in bowel habit, visible bleeding, iron-deficiency anaemia, unexplained weight loss, a palpable mass, significant family history or eligibility under a current screening pathway. The appropriate test and urgency depend on age, risk, examination and local Indian services.
Why can more fibre make some people with constipation feel worse?
Rapidly increasing coarse or insoluble fibre can increase gas, bloating and stool bulk. It may be poorly tolerated when intake is already high, faecal impaction is present, transit is very slow or the pelvic floor cannot evacuate effectively. Fibre should be individualised, increased gradually when suitable, and accompanied by adequate fluid; worsening outlet symptoms should prompt reassessment.
What should happen when several laxatives have not worked?
First verify the diagnosis, exact medicines, dose, duration, adherence and secondary causes. Persistent blockage, prolonged straining or digital assistance warrants assessment for a defecatory disorder, usually with anorectal manometry and balloon expulsion in specialist care. Confirmed dyssynergia is treated with biofeedback. Slow-transit testing and advanced medicines follow a structured evaluation; surgery is exceptional, not the automatic next step.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic